Abstracts S377
Table 1 Continued
Gene Variant Inheritance UltrasoundfindingsinadditiontoNIHF
PTPN11 NM_002834.4:c.854T>C denovo Mildventriculomegaly,suspectedaorticcoarctation,absentDV,biventricular
[p.Phe285Ser] hypertrophy,pelviectasis,hepatomegaly,polyhydramnios
KRAS NM_033360.3:c.220A>C denovo VSD,leftSVCdrainingintocoronarysinus,SUA,polyhydramnios
[pThr74Pro]
KRAS NM_033360.3:c.204G>C denovo AbsentCSP,cardiomegaly,hepatomegaly,clubbedfeet,placentomegaly
[p.Arg68Ser]
BRAF NM_004333.5:c.1741A>C denovo FGR,echogenicbowel,SUA
[p.Asn581His]
RIT1 NM_006912.5:c.245T>G denovo CNSmalformation,congenitalheartdefect
[p.Phe82Cys]
Abbreviations:CNS,centralnervoussystem;CSP,cavumseptumpellucidum;DV,ductusvenosus;FGR,fetalgrowthrestriction;SUA,singleumbilicalartery;
NIHF,nonimmunehydropsfetalis;SVC,superiorvenacava;VSD,ventralseptaldefect.
https://doi.org/10.1016/j.gim.2022.01.597
OP052
Geneticetiologyofprenatallydetectedisolated moderatetosevereventriculomegaly
EricaSchindewolf1,ReneeDiCicco1,KendraMiller1,Rosa Hwang1,JulianaGebb1, AnaCristancho1,EdwardOliver1,
JulieMoldenhauer1
1TheChildren'sHospitalofPhiladelphia
Introduction: Ventriculomegaly (VM) is identified on prenatalultrasoundin 0.3-2.0 per 1000 pregnanciesand is categorizedinto three groups based on
measurementattheatriallevel:mild(≥10-<12mm),moderate(≥12-<15mm),andsevere(≥15mm).Theliteraturesuggeststhatapproximately2to15%of
fetuseswithidentifiedVMhaveanabnormalkaryotype,withlowerprevalenceinisolatedcases(1.5-12%)comparedtocaseswithadditionalanomalies(9.5-
36%).Infectiousetiologiesandclottingdisordersarecausalinsome.IsolatedVMhasbeenassociatedwithmanytypesofchromosomalanomalies,themost
commonbeingtrisomy21.Otherchromosomalabnormalities(trisomy18,trisomy13,monosomyX,andtriploidy),largedeletionsandduplications(1qdup,
7pdup,5pdel,and4pdel),microdeletionsyndromes(22q11.2del,15q11.2microdel,16p13.11microdelandmicrodupl,1p36microdel)andsinglegene
disorders (L1CAM, AP1S2, MPDZ, CCDC88C, EML1, WDR81, NSD1) have also been reported. The objective of this study was to describe the genetic
differencesseeninourcohortoffetusesprenatallydiagnosedwithisolatedmoderatetosevereVM.
Methods:ThiswasaretrospectivecohortstudyofpatientsthatwerereferredforVMbetweenApril2016toAugust2021.Patientswereevaluatedbyhigh
resolutionultrasoundandfetalneuroMRIandofferedgeneticcounselingandtesting.Atotalof144patientswereidentifiedofwhich50wentontohave
postnatalneurologyevaluation.54pregnanciesresultedinterminationsand13pregnanciesweredeliveredbutlosttofollowup.
Results:Ofthe131patientsidentified,70hadisolatedVMand61hadadditionalstructuralanomaliesthatexcludedthemfromtheanalysis.Inisolatedcases,
67% (47/70) had genetic testing and 40% (19/47)of those had abnormal results(Table 1). 74%(35/47) had cytogenetic testing including karyotypeand
microarray.11%(4/35)ofpatientswhounderwentcytogenetictestinghadabnormalmicroarray,allofwhichwerethoughttobecausativeoftheprenatal
findings.40%ofpatients(19/47)hadsinglegenenextgenerationsequencingandofthose31.5%(6/19)hadpositivetestresults,allofwhichwerethoughttobe
causal.30%(14/47)ofpatientshadExomeSequencing(ES).64%(9/14)hadpositiveresults,67%(6/9)ofwhichwerefelttobecontributorytodisease,with
anadditionalvariantofuncertainsignificanceandtwopathogenicfindingsthatwereunrelatedtoVMbutdidimpactclinicalmanagement.Onepatienthad
CMVinfectionandanotherhadNeonatalAlloimmuneThrombocytopenia.
Conclusion:AdvancesingenetictestinghaveallowedustoidentifyetiologiesofVMthatwerepreviouslyunknown.Astechnologyhasimproved,patients
withVMhavegainedmoremeaningfultestresultsasevidencedbyourESfindings.Our30%diagnosticratedoesnotrepresentthefullgeneticpotentialofthis
cohortasbarrierstogenetictestingstillexistsuchascost,timing,andunderstandingoftestingstrategy.Aportionofthispopulationwaslosttofollowup,
declinedprenataltesting,orhadworkupthatincludedonlycytogenetictesting.Thiscohortrepresentstheneedforastandardizedapproachtotestingstrategy
inthosewithprenatallydetectedisolatedmoderatetosevereVM.AproposedtestingstrategyforcasesofprenatallyidentifiedmoderateorsevereVMshould
include 1) diagnostic testing for chromosomal abnormalities with a karyotype and microarray, 2) Infectious PCR Testing and Neonatal Alloimmune
Thrombocytopeniaworkup,3)L1CAMgenesequencingforaffectedmales,and4)considerationofexomesequencing(ES).
S378 Abstracts
TypeofTesting Positive Negative Geneticalteration
SingleGene 31.5%(6/19) 68%(13/19) L1CAM
COL4A1
CCCND2
ExomeSequencing 64%(9/14) 36%(5/14) TRIM37
CHD7
FANCA
TUBA1
GRIN2B
GLI3
KIRREL3
OCA2(incidental)
KCNB2(incidental)
Miscellaneous 100%(2/2) 0%(0/2) CMVInfection,Neonatal
Thrombocytopenia
https://doi.org/10.1016/j.gim.2022.01.598
OP053
Barrierstocompletionofexpandedcarrierscreeninginaninnercitypopulation
Tirtza SpiegelStrauss1,EmilySchneider1,EmilyBoniferro1,Anna Johnson1, ErikaBrockhoff1, KristinaFeldman1,
Olivia Grubman1, FarrahHussain1,DavidCole1, GrahamAshmead1,ZainabAl-Ibraheemi1, LoisBrustman1
1MountSinaiWest,IcahnSchoolofMedicine atMountSinai
Introduction:TheAmericanCollegeofMedicalGeneticsandGenomicsemphasizestheneedfora“consistentandequitableapproachforofferingcarrier
screeningtoallindividualsduringpregnancyorpreconception”inordertofacilitateinformedreproductivedecisions.Atouracademiccenter,publiclyinsured
patientsobtainingprenatalcareunderwentuniversalExpandedCarrierScreening(ECS)topromoteequitableaccessandcare.Weevaluatedbarrierstotimely
ECScompletion,namely,receiptofgeneticcounseling,partnerscreening,andabilitytoactondiagnostictestingresults.
Methods:Adescriptiveretrospectivecohortstudywasperformedfrom2018-2021wherepatientswereofferedanECSpanelconsistingof283recessiveand
X-linkedpathogenicvariants.Womenwhowerefoundtobeheterozygousforrecessivepathogenicvariantswerecontactedbygeneticcounselors(=/>5
attempts),foreducationonthefindingandforpartnerstoreceiveatestkit.Prevalenceofpatientswhowereheterozygotesandratesofgeneticcounseling,
partnerscreening,diagnosticproceduresandtimetofollowupwereassessed.
Results:Therewere987firstprenatalvisitsand643womenunderwentECS.MediangestationalageatECSwas12weeksand3days.Resultswereabnormal
in462women(71.8%),whowereheterozygousforamedianof2pathogenicvariants(recessiveorX-linked).Geneticcounselingoccurredin326women
(70.6%)withabnormalresults,and136women(29.4%)didnothavefurtherfollowup.Twohundredtwenty-twopartners(48%)obtainedscreening,witha
medianof32daysfrompatienttopartnerresult.Therewere21coupleswhowerefoundtobeheterozygousforthesamerecessivepathogenicvariant,ofwhich
13(62%)werevariantsforrecessivediseasesthatwouldnotbedetectedbyNewYorkState’snewbornscreen.3womenpursueddiagnostictesting,with1
fetusaffectedleadingtotermination.
Conclusion:ECSoffersusefulinformation,however,ourdatasuggeststherearesignificantbarrierstofollowupinourdiversepopulation.Theprevalenceof
heterozygotesonECSinourpopulationwashigherthanexpected,whichleadtostrainsonoursystem,causingdelaysinfollowup.Therewerealsosuboptimal
patientfollowupandlowpartnerscreeningrates,possiblyduetolackoftimetocounselandeducate.Futuredirectionsincludeassessingdisparitiesand
implementingqualitymeasurestoensurecouples’completionofECS.
https://doi.org/10.1016/j.gim.2022.01.599
OP054
Chromosomalmicroarrayanalysisforopenneuraltubedefect:Theprevalenceofsignificantresultsandimplicationson
inuterorepair
RoniZemetLazar1,EyalKrispin2,RebeccaJohnson2,NavyaKumar3,AhmedNassr2,MagdalenaSanzCortes2,JimmyEspinoza2,
Michael Belfort2,AlirezaShamshirsaz2,IgnatiaVanDenVeyver4
1DepartmentofMolecular andHumanGenetics,BaylorCollegeofMedicine,Houston, TX;2Department ofObstetricsand
Gynecology,DivisionofFetalTherapyandSurgery,BaylorCollegeofMedicineandTexasChildren’sFetalCenter,Houston,
TX;3BaylorCollegeofMedicine,Houston,TX;4DepartmentofMolecularandHumanGeneticsandDepartmentofObstetrics
andGynecology,BaylorCollegeofMedicine, Houston,TX
Introduction:Openneuraltubedefects(ONTD)arethesecond-most-commonmajorcongenitalanomaly,andhavebeenassociatedwithenvironmentalinsults
orgeneticfactors.Prenatalscreeninganddiagnosisarewidelyavailable,andinuterorepairhasdemonstratedsuperioroutcomesforeligiblepatients.The
ManagementofMyelomeningoceleStudy(MOMS)requiredanormalkaryotypeasoneoftheeligibilitycriteriaforinuterorepair.However,currentguidelines
